HHS recently announced that it will provide more than $22 billion in funding to states, localities, and territories to support COVID-19 testing and vaccination.
Over $19 billion of the funding,...
Moderna recently announced that the European Commission (EU) granted conditional marketing authorization (CMA) for its mRNA COVID-19 vaccine.
The authorization of COVID-19 Vaccine Moderna,...
AstraZeneca recently announced that its COVID-19 vaccine has been granted emergency use authorization in India, Argentina, Dominican Republic, El Salvador, Mexico, and Morocco.
The authorization of...
FDA is warning health officials to follow the authorized dosing schedules for COVID-19 vaccines as the first round of recipients become eligible to receive their second dose.
Despite discussions...
Moderna recently released a COVID-19 vaccine manufacturing update for its mRNA-based vaccine, mRNA-1273. The company announced that it is increasing its base-case global production estimate from 500 to...
AstraZeneca recently announced that its COVID-19 vaccine has been approved for emergency supply in the United Kingdom (UK).
This is the first emergency authorization for COVID-19 Vaccine...
Pfizer and BioNTech recently announced that an additional 100 million doses of their mRNA COVID-19 vaccine will go to 27 European Union (EU) member states this year.
The commitment comes just...
Pfizer and BioNTech recently announced additional data on neutralizing antibody and T cell responses from the Phase 1/2 clinical trial of its COVID-19 vaccine candidate in Germany.
Specifically,...
California Governor Gavin Newsom recently launched a campaign for safe, fair, and equitable distribution of a COVID-19 vaccine in all 58 counties of the state.
The “Vaccinate All 58”...
HHS recently announced that the CDC will award an additional $227 million for COVID-19 vaccine preparedness and response activities.
Specifically, $140 million will be used for vaccine preparedness...
A two-dose regimen of Pfizer and BioNTech’s mRNA COVID-19 vaccine, BNT162b2, elicited 95 percent protection against the coronavirus in individuals 16 years of age or older, according to a recent...
The Trump Administration, through HHS and the Department of Defense (DoD), will purchase an additional 100 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273.
mRNA-1273 would...
Sanofi and GSK recently announced they will delay a program testing an adjuvanted COVID-19 vaccine after results from a Phase 1/2 study showed a low immune response in older adults.
The...
Moderna recently announced that the Canadian Government will now acquire an additional 20 million doses of its mRNA COVID-19 vaccine, bringing the total to 40 million doses.
The updated...
Moderna recently announced that the first adolescent patients have been dosed in the Phase 2/3 study of its mRNA-based COVID-19 vaccine, mRNA-1273.
The randomized, controlled Phase 2/3 study will...
The US Food and Drug Administration (FDA) has issued the first emergency use authorization (EUA) for a COVID-19 vaccine to Pfizer-BioNTech, allowing for distribution across the country.
The totality...
Following a positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, FDA stated that it will rapidly work toward finalization and issuance of an emergency use...
HHS recently announced that all tribal health programs and Urban Indian Organizations (UIOs) have chosen their preferred method for receiving a COVID-19 vaccine.
Tribal health programs and UIOs have...
FDA recently authorized the first at-home influenza and COVID-19 diagnostic test intended for patients who are suspected of respiratory viral infection consistent with the coronavirus.
The test,...
The implementation of a COVID-19 vaccination program will contribute more to the success a vaccine than drug efficacy, according to a recent Health Affairs study.
The study’s findings could...
